BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28639716)

  • 1. Expression of the autoantigen TRIM33/TIF1γ in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress.
    Scholtissek B; Ferring-Schmitt S; Maier J; Wenzel J
    Clin Exp Dermatol; 2017 Aug; 42(6):659-662. PubMed ID: 28639716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.
    Mohassel P; Rosen P; Casciola-Rosen L; Pak K; Mammen AL
    Arthritis Rheumatol; 2015 Jan; 67(1):266-72. PubMed ID: 25186009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis.
    Elst EF; Klein M; de Jager W; Kamphuis S; Wedderburn LR; van der Zee R; Albani S; Kuis W; Prakken BJ
    Arthritis Rheum; 2008 Feb; 58(2):547-55. PubMed ID: 18240224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis.
    Kotobuki Y; Tonomura K; Fujimoto M
    Immunol Med; 2021 Mar; 44(1):23-29. PubMed ID: 32649853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.
    Shrestha S; Wershil B; Sarwark JF; Niewold TB; Philipp T; Pachman LM
    Arthritis Rheum; 2010 Sep; 62(9):2813-22. PubMed ID: 20506305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis.
    Uruha A; Allenbach Y; Charuel JL; Musset L; Aussy A; Boyer O; Mariampillai K; Landon-Cardinal O; Rasmussen C; Bolko L; Maisonobe T; Leonard-Louis S; Suzuki S; Nishino I; Stenzel W; Benveniste O
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):513-522. PubMed ID: 30267437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis.
    Cordel N; Derambure C; Coutant S; Mariette X; Jullien D; Debarbieux S; Chosidow O; Meyer A; Bessis D; Joly P; Mathian A; Levesque H; Sabourin JC; Tournier I; Boyer O;
    Rheumatology (Oxford); 2021 Dec; 60(12):5863-5867. PubMed ID: 33764396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological biomarkers in dermatomyositis.
    Olazagasti JM; Niewold TB; Reed AM
    Curr Rheumatol Rep; 2015 Nov; 17(11):68. PubMed ID: 26404949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.
    Allenbach Y; Leroux G; Suárez-Calvet X; Preusse C; Gallardo E; Hervier B; Rigolet A; Hie M; Pehl D; Limal N; Hufnagl P; Zerbe N; Meyer A; Aouizerate J; Uzunhan Y; Maisonobe T; Goebel HH; Benveniste O; Stenzel W;
    Am J Pathol; 2016 Mar; 186(3):691-700. PubMed ID: 26806087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.
    Fujimoto M; Hamaguchi Y; Kaji K; Matsushita T; Ichimura Y; Kodera M; Ishiguro N; Ueda-Hayakawa I; Asano Y; Ogawa F; Fujikawa K; Miyagi T; Mabuchi E; Hirose K; Akimoto N; Hatta N; Tsutsui K; Higashi A; Igarashi A; Seishima M; Hasegawa M; Takehara K
    Arthritis Rheum; 2012 Feb; 64(2):513-22. PubMed ID: 21987216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus.
    Nakamura K; Jinnin M; Kudo H; Inoue K; Nakayama W; Honda N; Kajihara I; Masuguchi S; Fukushima S; Ihn H
    Br J Dermatol; 2016 May; 174(5):1030-41. PubMed ID: 26713607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis.
    Ogata A; Endo M; Aoi J; Takahashi O; Kadomatsu T; Miyata K; Tian Z; Jinnin M; Fukushima S; Ihn H; Oike Y
    Biochem Biophys Res Commun; 2012 Feb; 418(3):494-9. PubMed ID: 22281496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of BAFF in the muscles of patients with dermatomyositis.
    Baek A; Park HJ; Na SJ; Shim DS; Moon JS; Yang Y; Choi YC
    J Neuroimmunol; 2012 Aug; 249(1-2):96-100. PubMed ID: 22575417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lesions of dermatomyositis with supervening fibrosis.
    Magro CM; Dyrsen M; Kerns MJ
    J Cutan Pathol; 2008 Jan; 35(1):31-9. PubMed ID: 18095992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
    Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.
    López De Padilla CM; Crowson CS; Hein MS; Pendegraft RS; Strausbauch MA; Niewold TB; Ernste FC; Peterson E; Baechler EC; Reed AM
    J Rheumatol; 2017 Jan; 44(1):117-124. PubMed ID: 27803134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis.
    Fujimoto M; Murakami A; Kurei S; Okiyama N; Kawakami A; Mishima M; Sato S; Seishima M; Suda T; Mimori T; Takehara K; Kuwana M
    J Dermatol Sci; 2016 Dec; 84(3):272-281. PubMed ID: 27693019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
    Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
    Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
    Muro Y; Sugiura K; Akiyama M
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
    Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
    Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.